Navigation Links
Inverness Medical Innovations Announces Fourth Quarter 2007 Results
Date:2/20/2008

p>

charges have been excluded from net income or loss because they have

a significant impact on results yet do not occur on a consistent or

regular basis in the Company's business.

(c) Amortization expense of $25.6 million and $5.4 million included in

the fourth quarter of 2007 and 2006 GAAP results, respectively,

including $10.2 million and $2.7 million charged to cost of sales,

$0.7 million and $1.0 million charged to research and development,

$14.6 million and $1.5 million charged to selling, general and

administrative expense, and $0.1 million and $0.2 million charged to

other income, in the respective quarters.

(d) Compensation costs of $5.3 million and $1.6 million associated with

stock-based compensation expense, including $0.3 million and $0.1

million charged to cost of sales, $0.9 million and $.5 million

charged to research and development and $4.1 million and $1.0

million charged to selling, general and administrative.

(e) Loss of $0.3 million associated with management's decision to

dispose of our SMB research facility.

(f) Write-offs in the amount of $0.7 million and $0.1 million during the

three months ended December 31, 2007, relating to inventory

adjustments recorded in connection with the acquisition of

Cholestech and HemoSense, respectively.

(g) Purchase of in-process research and development during the three

months ended December 31, 2007 includes a write-off of $4.8 million

associated with the value of in-process research and development

costs incurred in connection with our acquisition of Diamics.

(h) A $3.9 million unrealized foreign currency loss associated with a

cash escrow established in connection with the acquisition of BBI

Holding
'/>"/>

SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
2. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
3. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
4. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
7. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
8. Inverness - Chemogen Establish Exclusive License for TB Antibodies
9. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
10. B-Line Medical and Immersion Medical Announce Partnership
11. MIT researcher addresses biomedical engineering challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Ariz. (PRWEB) May 23, 2013 SynCardia ... first and only FDA, Health Canada and CE (Europe) ... Science Centre in Scotland, which boasts more than 380,000 ... Artificial Heart powered by the Freedom® portable driver ... of the most advanced exhibitions of its kind. ...
(Date:5/23/2013)... Bed bugs compromised Penn State. A ... it. Meanwhile, My Cleaning Products offered complimentary samples of its ... pests without using harmful chemical elements. , Based on ... affected building was actually a dormitory , My Cleaning ... on May 13 and bed bug presence was confirmed on ...
(Date:5/23/2013)... Just released this month on Amazon and ... Barbara Roche: “Commit to Confidence: 30 Strategies to Help ... tips and quotes from the fields of psychology and business, ... that readers can do on their own or with a ... and professional goals. , “My book is a ...
(Date:5/22/2013)... 2013 iLuv Creative Technology, the premier ... the mobile lifestyle, announces they are now shipping MultiCharger-X, ... multiple iPad devices efficiently. Winner of the 2013 internationally ... Design award, MultiCharger-X is revolutionizing the way businesses, schools, ... deployed. , MultiCharger-X (iAD910) combines the ...
Breaking Biology Technology:SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3
... Ventures, specializing,in seed and early-stage investments in next-generation ... firm,s investment team with,the appointment of Richard Ulevitch, ... promotion of two of the firm,s senior associates, ... to Principal. Drs. Forrest,and McMillan have been with ...
... Feb. 20 Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ... milestone payment from Johnson & Johnson Pharmaceutical,Research & ... agreement., The two companies entered into a ... molecule enzyme inhibitors for the treatment of major,chronic ...
... ImmunoVaccine Technologies Inc. (IVT),a vaccine development company, announced ... the new Board of Directors Chair. Michael Kirby,succeeds ... leadership,during his tenure and was instrumental in spinning ... am passionate about advancing health care and am ...
Cached Biology Technology:5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal 25AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal 3Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration 2ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair 2
(Date:5/23/2013)... at Rollins School of Public Health at Emory ... of Technology, have received a $4 million grant ... at Emory University (Health and Exposome Research Center: ... exposome-based center grant awarded in the United States. ... the National Institute of Environmental Health Sciences (NIEHS) ...
(Date:5/23/2013)... The tight wrapping of genomic DNA around nucleosomes ... gene expression. A team of Ludwig-Maximilians-Universitaet (LMU) in ... DNA to be locally displaced from nucleosomes for ... is stored in the cell nucleus, wrapped around ... pairs of four different histone proteins and accommodating ...
(Date:5/23/2013)... unnecessarily undergo surgery or harsh treatments because science ... aggressive forms of the disease. Researchers at Case ... are developing technology that allows patients to safely ... treatments or take drastic measures. , The project ... professor of biomedical engineering at Case Western Reserve ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Biochemistry: Unspooling DNA from nucleosomal disks 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... more than 130 osteoporosis patient society representatives gathered in ... World Wide Conference of Osteoporosis Patient Societies. ... results in fractures in as many as one in ... age of 50 worldwide. International Osteoporosis Foundation (IOF) ...
... Stefan Herlitze, the Chair of the Department of Zoology and ... mice if, a week after birth, they eliminated a particular ... into nerve cells. "It,s the first time that we have ... Prof. Herlitze. "We can now start conducting research to develop ...
... a subtropical, deciduous fruit tree grown in most Mediterranean-type ... oldest cultivated fruit species on earth, global expansion of ... base pertaining to production practices and the limited number ... were established in the Mediterranean-type climate of Western Cape ...
Cached Biology News:Important role for the cerebellum 2Optimizing yield and fruit size of figs 2
... APAgene kits are designed to rapidly ... using our patented APA Technology. APAgene provides ... competitive price. All necessary ingredients are provided ... can be used for gap filling, localized ...
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Rabbit polyclonal to Yaf9 ( Abpromise for all tested applications)....
... to deparaffinize and perform Heat Induced Antigen ... sections mounted on glass microscope slides. Deparffinization ... the high temperature used in HIER (over ... paraffin by detergent. Formaldehyde fixation impairs or ...
Biology Products: